PT809493E - Metodo para o tratamento de doencas epiteliais hiperproliferativas da pele atraves da aplicacao topica de compostos de recticulacao de proteinas aromaticas hidroxilados - Google Patents

Metodo para o tratamento de doencas epiteliais hiperproliferativas da pele atraves da aplicacao topica de compostos de recticulacao de proteinas aromaticas hidroxilados

Info

Publication number
PT809493E
PT809493E PT96905555T PT96905555T PT809493E PT 809493 E PT809493 E PT 809493E PT 96905555 T PT96905555 T PT 96905555T PT 96905555 T PT96905555 T PT 96905555T PT 809493 E PT809493 E PT 809493E
Authority
PT
Portugal
Prior art keywords
treating hyperproliferative
hyperproliferative skin
top application
hydroxylated aromatic
skin epithelial
Prior art date
Application number
PT96905555T
Other languages
English (en)
Inventor
Terrence R Burke Jr
Stuart H Yuspa
Caroline Stanwell
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Publication of PT809493E publication Critical patent/PT809493E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT96905555T 1995-02-17 1996-02-14 Metodo para o tratamento de doencas epiteliais hiperproliferativas da pele atraves da aplicacao topica de compostos de recticulacao de proteinas aromaticas hidroxilados PT809493E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/389,845 US5610185A (en) 1995-02-17 1995-02-17 Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds

Publications (1)

Publication Number Publication Date
PT809493E true PT809493E (pt) 2003-01-31

Family

ID=23539975

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96905555T PT809493E (pt) 1995-02-17 1996-02-14 Metodo para o tratamento de doencas epiteliais hiperproliferativas da pele atraves da aplicacao topica de compostos de recticulacao de proteinas aromaticas hidroxilados

Country Status (11)

Country Link
US (1) US5610185A (pt)
EP (1) EP0809493B1 (pt)
JP (1) JPH11503111A (pt)
AT (1) ATE223715T1 (pt)
AU (1) AU698414B2 (pt)
CA (1) CA2212888C (pt)
DE (1) DE69623595T2 (pt)
DK (1) DK0809493T3 (pt)
ES (1) ES2183938T3 (pt)
PT (1) PT809493E (pt)
WO (1) WO1996025159A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321307A1 (en) 1998-02-27 1999-09-02 Venkatachala L. Narayanan Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
FR2778560B1 (fr) 1998-05-12 2001-06-01 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition destinee a favoriser la desquamation de la peau, et composition le comprenant
GB2370989A (en) * 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
PT1511710E (pt) * 2002-05-31 2014-02-26 Proteotech Inc Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson
US7368593B1 (en) 2003-08-18 2008-05-06 Organics L.L.C. Method of selective esterification
US20080125485A1 (en) 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
ES2238924B1 (es) 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
US20070149618A1 (en) 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
WO2005092322A1 (ja) * 2004-03-29 2005-10-06 Japan Health Sciences Foundation Ｒａｒ活性化を起こす天然化合物
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
FR2892923B1 (fr) * 2005-11-08 2009-01-16 Engelhard Lyon Sa Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
US8541467B2 (en) 2006-08-16 2013-09-24 Action Medicines, S.L. Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
US20080114075A1 (en) 2006-08-16 2008-05-15 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492815A1 (fr) * 1980-10-23 1982-04-30 Sori Soc Rech Ind Nouveau derive d'acide cinnamoyl-cinnamique, son procede de preparation et son application en therapeutique
US4925877A (en) * 1986-02-25 1990-05-15 Zaidanhojin Biseibutsu Kagaku Kenkyukai Physiologically active erbstatin analogue compounds and compositions
FR2601670B1 (fr) * 1986-07-17 1988-10-07 Cird Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
JPH03109323A (ja) * 1989-09-22 1991-05-09 Microbial Chem Res Found 抗ガン剤
US5360815A (en) * 1993-06-23 1994-11-01 Merck Frosst Canada, Inc. Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis
JPH0761919A (ja) * 1993-08-26 1995-03-07 Kao Corp 美白剤

Also Published As

Publication number Publication date
CA2212888A1 (en) 1996-08-22
EP0809493B1 (en) 2002-09-11
DE69623595T2 (de) 2003-05-22
EP0809493A1 (en) 1997-12-03
ES2183938T3 (es) 2003-04-01
DE69623595D1 (de) 2002-10-17
AU698414B2 (en) 1998-10-29
CA2212888C (en) 2006-10-17
DK0809493T3 (da) 2002-12-23
JPH11503111A (ja) 1999-03-23
ATE223715T1 (de) 2002-09-15
US5610185A (en) 1997-03-11
WO1996025159A1 (en) 1996-08-22
AU4928696A (en) 1996-09-04

Similar Documents

Publication Publication Date Title
PT809493E (pt) Metodo para o tratamento de doencas epiteliais hiperproliferativas da pele atraves da aplicacao topica de compostos de recticulacao de proteinas aromaticas hidroxilados
AU3142195A (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
DE69706566T2 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
EP0742012A3 (en) Pharmaceutical composition containing substance inhibiting HSP47 production
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
WO1996023489A3 (de) Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
AU3202595A (en) 1,2-substituted imidazolyl compounds for the treatment of inflammation
ES2137554T3 (es) 2-(2-amino-3-metoxifenil)-4-oxo-4h-(1)benzopirano para el tratamiento de desordenes proliferantes.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
KR970705990A (ko) 피부 질환 치료용 조성물(Compositions for the Treatment of Skin Disorders)
IT1275960B1 (it) Preparati igienici e cosmetici per prevenire e trattare malattie della pelle nonche' procedimento per il loro ottenimento
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
AR003971A1 (es) Utilizacion de al menos un acido dihidroxibenzoico, procedimiento de tratamiento cosmetico mediante una composicion que contiene dicho acido, y unacomposicion cosmetica y/o dermatologica que contiene dicho acido.
DE59409394D1 (de) Therapeutisches system zur behandlung der psoriasis
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
Weissmann et al. Photochemotherapy of psoriasis: effects on bacteria and surface lipids in uninvolved skin
AU2089088A (en) Pharmaceutical composition
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
PT865278E (pt) Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele
RU95109775A (ru) Способ лечения эпикантуса
CA2126704A1 (en) Dermatological Compositions and Methods for the Treatment of Skin Therewith
ATE206036T1 (de) Kombination eines zinksalicylats und eines serenoa repens-extrakts zur behandlung der seborrhö und diese enthaltende kosmetische hautpflegemittel
IT1268409B1 (it) Prodotto per il trattamento terapeutico di dermatiti da contatto e psoriasi